Teleflex Incorporated Common Stock (TFX)
Stock · NYSE · Health Care
$130.4as of 10/16/2026
Price chart
Active signals
TFX Signal Track Record
How signals performed across all stocks →What TFX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -1.5% | 45% | September 28, 2026 |
| Bollinger Band Breakdown | 24 | -2.0% | 46% | September 17, 2026 |
| 200-Day Moving Average TouchActive now | 20 | +0.1% | 50% | October 2, 2026 |
| Bollinger Band BreakoutActive now | 20 | -0.2% | 50% | August 4, 2026 |
| Any 20-session window (baseline) | -1.8% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning sys…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 15,500
- Website
- www.teleflex.com/usa/en/#
Fundamentals
- 1-day range
- $129.08$131.21
- Market cap
- $6.15B
- P/E (trailing)
- —
- P/E (forward)
- 11.97
- EPS (trailing)
- $-23.29
- Dividend yield
- 0.62%
- Beta
- 0.85
- Avg. volume
- 677.1K
- Ex-dividend date
- August 14, 2026
- Dividend pay date
- September 30, 2026
How Teleflex Incorporated Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub
Forecasts
11 analyst ratings
Teleflex Incorporated Common Stock Competitors
Chosen by industry and closest market cap.
- TFXTeleflex Incorporated Common Stock$130.43▲ 1.72%Market cap $6.15BP/E —$100.18$145
- STVNStevanato Group S.p.A. Ordinary Shares$18.9▼ 1.82%Market cap $6.14BP/E 34.82$12.89$27.99
- MMSIMerit Medical Systems Inc. Common Stock$89.2▼ 0.41%Market cap $5.24BP/E 36.22$59.74$94.75
- MMEDMiniMed Group Inc. Common Stock$17.49▼ 2.83%Market cap $5.17BP/E —$10.65$24.43
- NVSTEnvista Holdings Corporation Common Stock$22.9▼ 2.55%Market cap $4.46BP/E 39.56$18.77$30.42
- IRTCiRhythm Holdings Inc. Common Stock$108.66▼ 0.63%Market cap $4.21BP/E —$100.7$212
- ICUIICU Medical Inc. Common Stock$162.99▼ 2.54%Market cap $4.16BP/E 135.90$113.37$192.85
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TFX Teleflex Incorporated Common Stock | $6.15B | — | $130.43 | ▲ 1.72% | $100.18$145 |
| STVN Stevanato Group S.p.A. Ordinary Shares | $6.14B | 34.82 | $18.9 | ▼ 1.82% | $12.89$27.99 |
| MMSI Merit Medical Systems Inc. Common Stock | $5.24B | 36.22 | $89.2 | ▼ 0.41% | $59.74$94.75 |
| MMED MiniMed Group Inc. Common Stock | $5.17B | — | $17.49 | ▼ 2.83% | $10.65$24.43 |
| NVST Envista Holdings Corporation Common Stock | $4.46B | 39.56 | $22.9 | ▼ 2.55% | $18.77$30.42 |
| IRTC iRhythm Holdings Inc. Common Stock | $4.21B | — | $108.66 | ▼ 0.63% | $100.7$212 |
| ICUI ICU Medical Inc. Common Stock | $4.16B | 135.90 | $162.99 | ▼ 2.54% | $113.37$192.85 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $142benzinga · 10/14/2026
- 3 Small-Cap Stocks Walking a Fine LineYahoo · 10/9/2026
- Bruker Gains 66.3% in a Year: What's Driving the Rally?Yahoo · 10/8/2026
- Full Transcript: Teleflex Q2 2026 Earnings CallBenzinga · 10/8/2026
- Reasons to Add Globus Medical Stock to Your Portfolio NowYahoo · 10/7/2026
- Charles River Gains 75.8% in a Year: What's Driving the Rally?Yahoo · 10/7/2026
- TFX or SONVY: Which Is the Better Value Stock Right Now?Yahoo · 10/6/2026
- Is It Prudent to Add Teleflex Stock to Your Portfolio Now?Yahoo · 10/6/2026
- 3 Healthcare Stocks That Concern UsYahoo · 10/2/2026
Insider Activity
Insider Actions →- Salmon Sean · September 8, 2026 · Grant4.4K
- Salmon Sean · September 8, 2026 · Grant674
- Stuart A. Randle · June 8, 2026 · Grant2.2K
- Stuart A. Randle · June 8, 2026 · Grant4.7K
- Stuart A. Randle · June 8, 2026 · Grant995
- Jason R. Weidman · June 8, 2026 · Grant26.1K
- Jason R. Weidman · June 8, 2026 · Grant54.0K
- Stuart A. Randle · June 7, 2026 · Tax Withholding4.1K @ $129.84
- Jaewon Ryu · May 15, 2026 · Grant2.4K
- Jaewon Ryu · May 15, 2026 · Grant1.1K
- Neena M. Patil · May 15, 2026 · Grant2.4K
- Neena M. Patil · May 15, 2026 · Grant1.1K
- Michael J. Tokich · May 15, 2026 · Grant1.1K
- Candace H. Duncan · May 15, 2026 · Grant2.4K
- Andrew A. Krakauer · May 15, 2026 · Grant2.4K
Institutional Ownership
March 31, 2026
- Total shares held
- 44.94M
- Total value held
- $4.66B
- Institutional holders
- 358
- Unknown5.39M
- Unknown4.29M
- Unknown3.84M
- Unknown1.98M
- Unknown1.59M
- Unknown1.53M
- Unknown1.50M
- Unknown1.36M
- Unknown1.18M
- Unknown1.14M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Teleflex Shares Lag Peers Amid Q2 Earnings and Value Debate
Teleflex (TFX) recently released its Q2 2026 earnings call transcript, which has fueled ongoing discussions about its valuation relative to peers like Sonovion. While some analysts highlight its status as a value stock, others have flagged concerns within the broader healthcare sector. The stock is currently trading near its 52-week low, reflecting a cautious market sentiment despite an average analyst target that remains significantly higher than the current price.
Teleflex Shares Lag Peers Amid Q2 Earnings and Value Debate. Teleflex (TFX) recently released its Q2 2026 earnings call transcript, which has fueled ongoing discussions about its valuation relative to peers like Sonovion. While some analysts highlight its status as a value stock, others have flagged concerns within the broader healthcare sector. The stock is currently trading near its 52-week low, reflecting a cautious market sentiment despite an average analyst target that remains significantly higher than the current price.